The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 05, 2019

Filed:

Aug. 09, 2016
Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

Tapas K. Das Gupta, River Forest, IL (US);

Craig W. Beattie, Chicago, IL (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/21 (2006.01); C07K 14/195 (2006.01); A61K 47/69 (2017.01); A61K 47/52 (2017.01); A61K 38/16 (2006.01); C07K 7/64 (2006.01);
U.S. Cl.
CPC ...
C07K 14/21 (2013.01); A61K 38/164 (2013.01); A61K 47/52 (2017.08); A61K 47/6929 (2017.08); C07K 7/64 (2013.01); C07K 14/195 (2013.01); C07K 2319/50 (2013.01); G01N 2333/16 (2013.01); Y02A 50/411 (2018.01);
Abstract

The present invention provides modified cupredoxin derived peptides with pharmacologic activity that have improved pharmacokinetic properties, and methods to use them to treat mammals suffering from various conditions related to the pharmacologic activities. Modifications of the cupredoxin derived peptides include amino acid sequence variants and structural derivations that increase the plasma half-life of the peptide, increase the specific activity of the pharmacologic activity, decrease immunogenicity, and decrease the biotransformation of the peptides. The modified cupredoxin derived peptides can be used in methods to treat mammals for cancer, conditions related to inappropriate angiogenesis, viral and bacterial infections, and specifically HIV and malaria, conditions related to ephrin signaling, and to deliver cargo compounds, including diagnostic compounds to cancer cell.


Find Patent Forward Citations

Quick Actions:

Das Gupta, Tapas. (2019). Modification of cupredoxin derived peptides (U.S. Patent No. 10196428). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10196428

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…